Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma. [electronic resource] by
- Hurwitz, Michael E
- Markowski, Paul
- Yao, Xiaopan
- Deshpande, Hari
- Patel, Jaymin
- Mortazavi, Amir
- Donadio, Alessia
- Stein, Mark N
- Kelly, William Kevin
- Petrylak, Daniel Peter
- Mehnert, Janice M
Producer: 20190624
In:
Clinical genitourinary cancer vol. 16
Availability: No items available.
|
|
6.
|
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors. [electronic resource] by
- Panda, Anshuman
- Betigeri, Anil
- Subramanian, Kalyanasundaram
- Ross, Jeffrey S
- Pavlick, Dean C
- Ali, Siraj
- Markowski, Paul
- Silk, Ann
- Kaufman, Howard L
- Lattime, Edmund
- Mehnert, Janice M
- Sullivan, Ryan
- Lovly, Christine M
- Sosman, Jeffrey
- Johnson, Douglas B
- Bhanot, Gyan
- Ganesan, Shridar
Publication details: JCO precision oncology 2017
In:
JCO precision oncology vol. 2017
Availability: No items available.
|